RoosterBio and Repligen Collaborate to Advance Scalable Exosome Bioprocessing
Repligen Appoints Martin D. Madaus to Board of Directors
Repligen Expands Process Analytics Portfolio with DRS Daylight Solutions Agreement.
Repligen Launches AAV Affinity Resins for Gene Therapy Purification
Repligen Acquires BioFlex Solutions, LLC
Repligen Releases Inaugural Sustainability Report
Repligen Announces Agreement to Acquire Avitide Inc
Repligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH Sensitive Antibodies
Repligen Extends Long Term Supply Agreement with Cytiva for Affinity Ligands
Repligen Corporation Announces Agreement to Acquire Polymem S.A.
Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines